DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio

Tuesday, 3 January 2017

Dr. Kurt Stoeckli, President & Chief Scientific Officer, Glenmark Pharmaceuticals ltd

Kurt Stoeckli

Dr. Kurt Stoeckli

President & Chief Scientific Officer
Glenmark Pharmaceuticals ltd
Neuchatel, Switzerland


Having spent more than two decades in the pharmaceutical arena, Dr. Stoeckli has extensive industry experience and joins us from Sanofi where he was Group Vice President for Global Bio Pharmaceuticals Division. He was on their R&D Board, and served as CSO for R&D, France. In his tenure of more than fifteen years with Sanofi he has held progressive leadership positions of – Vice President, Global Head of Therapeutic Unit -Immuno-Inflammation, Vice President - Biological Sciences & Scientific Site Director, Vice President of Biological Sciences, Member of the Sanofi Aventis Discovery Board, Global Head of Discovery Technologies, and lastly Vice President, Global Lead Discovery, Aventis Pharma. Prior to joining Sanofi, Dr. Stoeckli worked for seven years in drug discovery at Novartis/Sandoz in Basel, Switzerland.
Dr. Stoeckli is Postdoctoral Fellow & Assistant Professor from Department of Biochemistry & Biophysics, University of California Medical Center and Ph.D., Cell Biology & Neurosciences from Max-Planck-Institute for Neurobiology.


Image result for glenmark
President & Chief Scientific Officer
Glenmark Pharmaceuticals ltd
Neuchatel, Switzerland
oct 1 2016.............

Vice President Global Biotherapeutics

 – Present (4 years)Paris Area, France
Global responsibility within R&D for biologics from discovery up until phase 3 support across therapeutic areas

Deputy to President of Global R&D (ad interim) for Research & Early Development

 –  (7 months)Paris Area, France
Global R&D Management

VP R&D Global Head Immuno-Inflammation Unit

 –  (2 years 3 months)Paris - Bridgewater
Therapeutic area head (Research & Early Development) in the area of immune-mediated and chronic inflammatory diseases

Vice President Biological Sciences & Scientific Director Vitry-Alfortville-Evry Site

 –  (1 year)Paris Area, France
Global head of research biologics
Member of R&D board
Scientific Director of Vitry-Alfortville-Evry Site

VP Biological Sciences, Discovery Research

 –  (1 year 5 months)Frankfurt Am Main Area, Germany
Responsibility for newly created research biologics with teams in Frankfurt, Paris, Toulouse, Bridgewater, Cambridge)

VP Lead Discovery Technologies

Sanofi Aventis
 –  (7 years 6 months)Frankfurt Area, Germany

Research Program Head

Novartis AG
 –  (7 years 3 months)Basel Area, Switzerland


Max Planck Society


Universität Basel

Doctor of Philosophy (Ph.D.)



No comments:

Post a Comment